Sanofi-aventis finalizes Chattem acquisition
Sanofi-aventis has completed its acquisition of U.S. drug maker Chattem Inc., which is now a subsidiary of the sanofi-aventis Group. Chattem’s common stock ceased trading on the Nasdaq Global Select Market after the market’s close on March 10, sanofi-aventis said Thursday.